Galderma Research & Development

Galderma Laboratories Inc.

Galderma S.a.

Galderma Research & Development Snc

Gladerma Research & Development Snc

Michael Graeber

Janusz Czernielewski

Matthew James Leoni

Christian Loesche

Philip Freidenreich

Jean Jacovella

Alexandre Kaoukhov

Michel Poncet

Jean-Paul Chappuis

Philippe Briantais

Yin-sang Liu

Laurence Salin

Jack A DeJovin

Isabelle Jean DeJovin

Yin Liu

Yin-Sang Liu

Guy Bouvier

Nathalie Sordello Wagner

Barbara Gore

Paul Martinetti

Bernadette Irene Mangione

Jerry Kim Leng Tan

Shannon Louise Moore

Diane Travaglini Rudisill

Valerie Tillier-LeFrancois

Jae Karlo Calandria Lopez

Alessandra Beatriz Alio-Saenz

Marie Helene Peirone

Khaled Benkali

Joyce Lee Hwa

Valerie Foley

Vasant Manna

Methods and compositions for safe and effective treatment of papulopustular rosacea in a subject are described. The methods involve topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. Treatment with ivermectin represents an innovative therapy that is more robust and effective than the conventional treatments.

Treatment of papulopustular rosacea with ivermectin

Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions.

Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders

Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.

Methods and compositions for safe and effective treatment of erythema

Dermatological disorders having an inflammatory or proliferative component, notably common acne, are treated with topically applicable pharmaceutical compositions containing about 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously formulated into topically applicable gels, preferably aqueous gels, creams, lotions or solutions.

Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid

Methods, compositions and products for preventing skin tumor formation or inhibiting the development of an existing skin tumor in a subject are described. The methods involve administering to the subject a composition containing an &#x3b1; adrenergic receptor agonist, such as brimonidine.

Method for preventing or treating skin tumor

Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders

Garment

Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.

Treatment of inflammatory lesions of rosacea with ivermectin

Dermatological disorders having an inflammatory or proliferative component, notably common acne, are treated with topically applicable pharmaceutical compositions containing about 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously formulated into topically applicable gels, preferably aqueous gels, creams, lotions or solutions.

Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid

Improved methods and compositions for safe and effective treatment of telangiectasia or a symptom associated with telangiectasia in a subject are described. The methods involve topically applying to an affected skin area a topical composition comprising about 0.3% to about 10% by weight of brimonidine and a pharmaceutically acceptable carrier.

Methods and compositions for safe and effective treatment of telangiectasia

Growing community of inventors

Lawrenceville, NJ, United States of America

Michael Graeber